『Lima Alpha Tablet, a treatment for lumbar spinal stenosis, launched』
KyungDong Pharm Co., Ltd. launches oral prostaglandin E1 derivative ‘Lima Alpha Tablets (5㎍ as Limaprost)’ in May 2013.
Lumbar spinal stenosis, a representative degenerative disease, accounts for 90% of patients in their 50s or older, and the number of patients is rapidly increasing every year due to the aging population. Except in special cases, initial treatment should consider non-surgical treatments such as rest, drug therapy, physical therapy, exercise therapy, and nerve blocks, and it is known that most respond well to these active treatments.
The main symptoms of lumbar spinal canal stenosis are lower extremity pain, paresthesia, and intermittent claudication. When these neurological dysfunctions occur, ‘Lima Alpha Tablets (5㎍ as Limaprost)’ improves them through vasodilation effects.
In addition, ‘Lima Alpha Tablets’ has secured high stability through a dry granulation manufacturing process that does not use water, considering its weak hygroscopicity.
♤ Product Information ♤
◇Product name: Lima Alpha tablets
◇Ingredient content: Lima Frost Alphadex 166.67㎍ (5㎍ as Lima Frost)
◇Effectiveness and dosage
1. Improvement of ischemic symptoms such as ulcers, pain, and cold sensation caused by obliterative thromboangiitis (Buerger's disease)
- Normally, adults take orally 3 times a day, 2 tablets at a time.
2. Subjective symptoms due to acquired lumbar spinal stenosis (patient with normal SLR test and bilateral intermittent claudication)
(pain in the lower extremities, numbness in the lower extremities) and improvement in walking ability
- Normally administered orally to adults 3 times a day, 1 tablet per time.
◇Insurance price: 322 won / T
◇Insurance code: 648103230
◇Packing unit: 84T
※ Please refer to the product manual for other details such as precautions for use.